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There is increasing interest in prediction and prevention of rheumatoid arthritis (RA). It is important 
to understand the views of those at risk to inform the development of effective approaches. First-
degree relatives (FDRs) of RA patients are at increased risk of RA. This study assessed predictors of 
their interest in predictive testing for RA.
Methods
Questionnaires were completed by RA patients (provided with their questionnaire by a healthcare 
professional) and their FDRs (provided with their questionnaire by their RA proband). FDR surveys 
assessed interest in taking a predictive test, demographic variables, perceived RA risk, attitudes about 
predictive testing, autonomy preferences, illness perceptions, avoidance coping and health anxiety. 
Patient surveys included demographic variables, disease impact, RA duration and treatment. Ordinal 
logistic regression examined the association between FDRs’ characteristics and their interest in 
predictive testing. Generalised estimating equations assessed associations between patient 
characteristics and FDRs’ interest in predictive testing. 
Results
396 FDRs responded. Paired data from the RA proband were available for 292. 91.3% of FDRs were 
interested in predictive testing. Information seeking preferences, beliefs that predictive testing can 
increase empowerment over health and positive attitudes about risk knowledge were associated with 
increased interest. Beliefs that predictive testing could cause psychological harm predicted lower 
interest. Patient characteristics of the proband were not associated with FDRs’ interest. 
Conclusions
FDRs’ interest in predictive testing for RA was high, and factors associated with interest were 
identified. These findings will inform the development of predictive strategies and informational 
resources for those at risk.
Key messages: 
 The majority of first-degree relatives were interested in taking a predictive test for RA.
 Information-seeking preferences, beliefs that predictive testing can increase empowerment 
over health, and attitudes towards risk knowledge predicted increased interest.
 Beliefs that predictive testing could lead to psychological harm predicted lower levels of 
interest.









































































Over recent decades, research has focussed on early rheumatoid arthritis (RA), and those at risk of 
developing RA, to facilitate early intervention and stratified approaches.[1-3]
Several prospective studies recruiting first-degree relatives (FDRs) are assessing the value of genetic 
and environmental variables with autoantibodies and inflammatory markers to predict RA 
development.[4-6] Interventions to reduce RA risk have also been tested in this group. These include 
200-400mg hydroxychloroquine taken daily for 12 months (trial data awaited),[7] and disclosure of 
personalised risk information.[8] FDRs who received such information were more likely to alter risk-
related behaviours, and less concerned about their risk of RA [9] than a control group receiving 
standard risk education.[8]
The clinical translation of research to predict and prevent RA will mean that at risk groups will be 
offered risk assessment. It is therefore important to understand their views to ensure risk information 
is communicated in a way that is sensitive to recipients’ needs and concerns.[10]
One qualitative study investigated FDRs’ perceptions of predictive testing for RA.[11] The majority had 
positive views towards predictive testing, feeling that it could increase awareness of early RA 
symptoms. Negative views related to uncertainty about test accuracy and potential for anxiety.[11] 
Further quantitative studies are needed to provide a robust understanding, including the impact of 
demographic and psychosocial characteristics on willingness to undergo predictive testing. 
Studies in other diseases have found that witnessing a family member being affected by that disease 
increased perceived vulnerability and motivation to engage in predictive approaches.[12,13] No 
studies have examined the influence of patients’ characteristics on FDRs’ perceptions towards 
predictive testing for RA. 
The aim of the current study is to define predictors of interest in predictive testing for RA amongst 
FDRs of patients with a diagnosis of RA.










































































Two cross-sectional surveys, one for patients with RA and another for their FDR, assessed interest in 
predictive testing and potential demographic and psychosocial predictors of such interest. This paper 
focuses on FDRs’ interest in predictive testing. 
Procedure
Patients with a confirmed diagnosis of RA were identified via outpatient clinics in the West Midlands, 
England between March 2017-January 2020. FDRs were eligible if they a) were biological children and/ 
or full siblings of a patient with RA; b) were aged 18 years or over; c) did not have a diagnosis of RA; 
and d) could complete a survey in English. All participants provided written, informed consent by 
completing a series of checkboxes to indicate that they agreed to take part. 
Patients were provided with a pack containing a survey for them and two for FDRs. Patients were 
invited to pass the latter onto FDRs and could request additional surveys if they wished to invite more 
than two. Patients were advised that FDRs could take part in the survey even if they themselves did 
not wish to. All participants were provided with a freepost envelope to return completed surveys. 
Surveys within each pack were labelled with a unique code, allowing FDR and patient surveys to be 
linked.
This study was approved by the Research Ethics Committee (Berkshire B): 16/SC/0369.
Measures 
Primary outcome measure
Interest in predictive testing was assessed using one item; “if, in the next 6 months your doctor offered 
you a test that predicted your risk of developing rheumatoid arthritis, would you take the test?”. 
Responses were measured on a 4-point Likert scale ranging from 0 (“no definitely not”) to 3 (“yes 
definitely”).  
Measures of potential predictors of FDRs’ interest in predictive testing
Selection of measures was informed by a literature review on interest in predictive testing and guided 
by the Self-Regulation Model of health behaviour.[14] Brief versions of relevant measures were 
included where available in response to patient partner assessment of cognitive burden for 
participants. FDRs reported gender, age, ethnicity, postcode, employment status, level of education, 
smoking status, relationship to index patient (child or sibling), whether they live with this patient and 








































































how often they talk to them. Demographic variables were found by previous studies to predict interest 
in predictive testing in other diseases such as cardiovascular disease (CVD) and type 2 diabetes 
(T2D).[15]
The survey included the following questionnaires: (1) The Brief Illness Perceptions Questionnaires 
(Brief IPQ), measured perceptions of RA in eight domains: consequences, timeline, personal control, 
treatment control, identity, concern, understanding and emotion. Items were scored on an 11-point 
scale, with higher scores indicating a more threatening view of RA.[16] The wording of items was 
modified for at-risk individuals, for example: “If you were to develop rheumatoid arthritis, how much 
do you think your treatment would help it?”.[17] This scale was shown to have good internal reliability 
and test-retest reliability in healthy individuals [17] and predict interest in predictive testing for cancer 
and heart disease.[18]
(2) The single item literacy screener (SILS), assessed health literacy. Responses were measured on a 5-
point scale from 0 (“never”) to 4 (“always”). This scale demonstrates good sensitivity (54%) and 
specificity (83%) in patients with diabetes.[19] Scores above 2 indicate difficulty reading health-related 
material.[19] Health literacy has been shown to be associated with health behaviours and self-
reported health status,[20] and interventions to increase health literacy improve behavioural 
outcomes.[21]
(3) The three-item subjective numeracy scale (SNS-3) was also included.[22] Each item was scored on 
a 6-point scale with scores ranging from 3-18. Higher scores indicate stronger perceived numeracy. 
This scale has good internal reliability (α=0.78) in patients with diseases such as chronic kidney disease 
and diabetes.[22] Understanding of numerical information has been shown to affect medical decision-
making.[23]
(4) The Autonomy Preference Index (API), measured health-related decision-making (6 items) and 
information-seeking preferences (8 items) [24] using a 5-point scale ranging from 0 (“strongly 
disagree”) to 4 (“strongly agree”). For each subscale, scores were converted into a scale from 0-100, 
with higher scores indicating greater autonomy preferences. This index has been found to have good 
internal consistency (α= 0.82) in a sample of diabetic patients [24] and predict interest in predictive 
testing for other conditions.[25,26]
(5) The Brief Approach/Avoidance Coping Questionnaire (BACQ), measured approach/avoidant coping 
style in stressful situations in cognitive, socioemotional and action-related domains.[27] This measure 
has 12 items, each measured using a 5-point scale ranging from 0 (“strongly disagree”) to 4 (“strongly 
agree”). Total scores range from 0-48, with higher scores indicating higher approach/lower avoidance 








































































coping styles. This scale demonstrated acceptable internal consistency (α= 0.68) in a large sample of 
primary care patients.[27] Coping styles have been found to be associated with health-related 
behaviour.[28] 
(6) Dispositional optimism was assessed using three items from the Life Orientation Test-Revised (LOT-
R). Each item was assessed using a scale ranging from 0 (“strongly disagree”) to 4 (“strongly agree”). 
Total scores ranged from 0-12, with higher scores indicating increased optimism.[29] This scale was 
shown to have strong internal consistency (α=0.82). Individuals with higher levels of optimism 
reported greater interest in taking a predictive genetic test, and greater intentions to use this 
information to change health behaviours.[30]
(7) The Short Health Anxiety Inventory (SHAI) assessed worry about health, awareness of bodily 
sensations and feared consequences of illness using 18 items and is associated with increased health 
information-seeking.[31] For each item, participants select one of four statements that best reflects 
their feelings over the past six months. Total scores range from 0-54, with scores above 27 indicating 
health anxiety.[32] This scale has been found to have high test-retest reliability (r=0.87) and internal 
consistency (α=0.95) in patients with hyperchondriasis, panic disorder and social phobia.[31] 
Four items assessed perceived lifetime risk of RA; absolute risk, relative risk, experiential risk and 
concern about risk. These were adapted from previous studies examining the association between 
perceived risk and interest in predictive testing or engagement in health behaviours.[18,30,33,34] 
Each was scored on a 5-point response scale, with higher scores indicating higher perceived risk.
Twenty-three attitudinal statements measuring perceived advantages (12 items) and disadvantages 
(11 items) of “finding out how likely it is that you will develop rheumatoid arthritis in the future” were 
adapted from Cameron et al,[18] with additional items based on themes identified in previous 
qualitative investigations [11,35,36] (a list of these statements is provided in Supplementary Data 
Section S1, available at Rheumatology online). Participants indicated the extent to which they agreed 
with each statement using a 5-point scale ranging from “strongly disagree” to “strongly agree”. 
Measures of patients’ characteristics 
For those FDRs for whom linked survey data were available from their index patient, measures of 
patients’ demographic and clinical characteristics were assessed, including reported gender, age, 
ethnicity, postcode, employment status, level of education, smoking status, years with RA, current 
treatment for RA and RA status measured using the Rheumatoid Arthritis Impact of Disease (RAID) 
scale (includes seven domains: pain, ability, fatigue, sleep, physical wellbeing, emotional wellbeing 
and coping; higher scores indicate worse disease status).[37] Each domain was measured on an 11-








































































point scale from 0 to 10, where 0 indicates no impact, and 10 indicates extreme impact. A total score 
was calculated taking into account the weight of each domain (pain 0.21, ability 0.16, fatigue 0.15, 
sleep 0.12, emotional wellbeing 0.12, physical wellbeing 0.12 and coping 0.12). Total scores range 
between 0-10, where higher scores indicate worse reported disease status.[37]
Analysis
Analyses were performed using IBM SPSS Statistics version 27.0.
Association between FDR characteristics and their interest in predictive testing 
Descriptive statistics were used to summarise demographic and psychosocial characteristics. Principal 
components analysis (PCA) with direct oblimin rotation was conducted to reduce the 23 attitudinal 
items into a smaller number of underlying factors. Original scores for each item were multiplied by 
factor loadings to obtain a weighted score. From this, a mean score was calculated.
Kruskal-Wallis H and Mann-Whitney U tests assessed the effects of categorical variables on interest in 
predictive testing. Spearman’s rank correlations were used to investigate associations between 
ordinal variables and interest in predictive testing. All predictor variables with a significance level 
<0.05 informed an ordinal logistic regression model using backward elimination, with interest in 
predictive testing recoded as “definitely interested”, “probably interested” and “not interested”. 
Association between patients’ characteristics and FDRs’ interest in predictive testing
Where possible, FDRs’ interest in predictive testing was paired with measures of index patients’ 
demographic and clinical characteristics.
Descriptive statistics summarised patients’ characteristics. 
Generalised estimating equations (GEEs) using an exchangeable working correlation matrix assessed 
the ability of patient characteristics to predict FDRs’ interest in predictive testing allowing for possible 
non-independence of FDRs paired with the same patient. This method of analysis offers a flexible tool 
for dealing with correlated data; in this case responses from a single patient could be related to more 
than one FDR. [38,39]
Sample size calculation
A sample size of 288 FDRs provides 95% confidence that an estimate of the proportion of positive and 
negative responses for the primary outcome variable was within 0.06 of the true value. Our 
multivariate ordinal regression analysis included 316 FDRs. 








































































Patient and public involvement 
Three patient research partners (PRPs) contributed to survey development, commenting on drafts of 
the protocol, study documents and surveys (via email), and attending a focus group to discuss survey 
design and content. They highlighted that issues raised in the survey might cause anxiety for some 
patients and FDRs, who may not have considered that they or their relatives might have an elevated 
risk status. As a result, potential patient participants were approached during clinic appointments by 
a member of the healthcare team rather than by mail, so they had the opportunity to raise any 
concerns. Participants were provided with an information resource about RA risk for family members 
of RA patients as part of a debriefing letter at the end of the survey. Patients diagnosed with RA within 
the previous six months were not approached, as PRPs felt that such patients may be experiencing 
anxiety associated with adjusting to diagnosis and treatment, and that it was not appropriate to invite 
these patients to take part in a study that may raise additional concern about the possibility of other 
family members developing RA. As a result of further PRP input, a subjective rather than an objective 
measure of numeracy was used, the patients’ survey was divided into two parts to allow for a break if 
necessary, tables of contents were included so participants were aware of the nature of survey 
questions before deciding to respond, and opportunities for open-ended responses were included.









































































Survey packs were provided to 1720 patients. 396 FDRs returned a survey; for 292 of these, paired 
data from 214 patients were available. In some cases, FDRs who returned a survey did not have a 
linked patient. In other cases, multiple FDRs were associated with one patient survey. For 148 patients 
one FDR completed the survey, 56 had two, eight had three and two had four. Analyses are presented 
separately for predictors relating to FDRs and to index patients.
The distribution of scores for FDRs’ interest in taking a predictive test within the following six months 
is described in Table 1. The majority (91.3%) reported being definitely or probably interested in taking 
a predictive test.
In the PCA of the 23 items describing advantages and disadvantages of predictive testing, factor 
loadings less than 0.3 were disregarded.[40] The KMO measure of sampling adequacy was 0.84. 
Bartlett’s test of sphericity was significant (p<0.001). A six-factor solution (Supplementary Table S1, 
available at Rheumatology online) explained 64.44% of the variance. Interpretation of the factor 
loadings labelled the factors as: 1) Desire for risk knowledge; 2) Psychological harm to self; 3) Increased 
empowerment over health; 4) Family (di)stress; 5) Accuracy of predictive testing and 6) Social 
consequences. 
FDRs’ demographic and psychosocial characteristics, and univariate analyses of their relationships 
with interest in predictive testing, are summarised in Table 2; 20 predictors were significantly 
associated with interest in predictive testing.
Measures of perceived risk were highly inter-correlated. Risk framed in absolute, rather than relative 
terms is less likely to affect health behaviour.[41] Therefore, as these results were intended to be 
informative for the development of information to support shared decision-making rather than 
indended to influence behaviour, absolute risk was the measure of risk perception included in the 
multivariate analysis.                  
Six variables were included in the final multivariate regression. A flow chart detailing this process is 
provided in Supplementary Figure S1 (available at Rheumatology online). The final model is outlined 
in Table 3.
Desire to obtain risk knowledge, information-seeking preferences, and beliefs that predictive testing 
would increase empowerment over health predicted increased interest in predictive testing. Those 
who perceived themselves to be “neither likely nor unlikely to develop RA”, or “unlikely to develop 
RA” had lower interest in predictive testing than those who perceived themselves to be “very likely to 
develop RA”. However, those who perceived themselves to be “very unlikely to develop RA” did not 








































































have a lower interest in predictive testing compared to those who felt “very likely to develop RA”. 
Finally, FDRs’ beliefs that predictive testing would result in psychological harm predicted decreased 
interest in testing. 
The multivariate model was replicated using relative risk instead of absolute risk as a sensitivity 
analysis. One small difference was found in results: for relative risk, those who felt they were “less 
likely to develop RA compared to other people their age, gender and race” did not have a lower 
interest in predictive testing compared to those who felt they were “much more likely to develop RA 
compared to other people their age, gender and race”. The relative risk multivariate model can be 
found in Supplementary Table S2 (available at Rheumatology online).                  
The association between patients’ characteristics and FDRs’ interest in predictive testing 
Descriptive statistics summarising demographic and clinical characteristics of index patients, and tests 
for the relationships between patients’ characteristics and FDRs’ interest in predictive testing for RA 
are presented in Table 4. 
FDRs were more interested in taking a predictive test if their index patient was male compared to 
female (p=0.05) and reported higher levels of RA pain (p=0.04). However, these characteristics only 
weakly predicted their FDRs’ interest in predictive testing and would not remain statistically 
significant when corrected for multiple comparisons.









































































This study is the first quantitative assessment of perceptions of predictive testing for RA amongst 
FDRs, and the impact of RA patients’ characteristics on FDRs’ interest in predictive testing. 
FDRs expressed high levels of interest in predictive testing for RA. This aligns with results from 
qualitative studies.[11,42] This study also confirms qualitative findings [11,43] that interest in 
predictive testing for RA was associated with  beliefs that such tests would be extremely accurate, and 
able to rule in/out future RA development. Such beliefs may help individuals to manage potentially 
complex risk information.[43,44] However, these mechanisms may impede understanding of risk 
information provided by healthcare professionals. Therefore, effective communication of the 
probabilistic nature of risk information for diseases such as RA presents a challenge for approaches to 
support shared decision-making in this context. 
Several predictors were associated with FDRs’ interest in predictive testing, including greater 
information-seeking preferences, beliefs that predictive testing would increase empowerment and 
attitudinal items reflecting a desire to obtain risk knowledge about RA. The influence of FDRs’ desire 
to obtain risk knowledge of RA and beliefs that tests would increase control over health on interest in 
testing is consistent with findings from studies in other diseases.[18,33] Increased health information-
seeking preferences were previously found to be associated with testing for Alzheimer’s  disease,[26] 
but not for hereditary breast or ovarian cancer.[45] 
The association between perceived risk and interest in predictive testing contradicts findings in other 
disease areas.[46] However, this finding should be interpreted with caution since few participants 
perceived themselves to be very unlikely to develop RA. 
FDRs were less interested in taking a predictive test if they agreed that risk information could cause 
psychological harm. This aligns with previous qualitative research highlighting concerns about the 
potential for anxiety about risk status.[11,43] Predictive approaches therefore should incorporate 
appropriate information and support.
Patients’ characteristics were not associated with FDRs’ interest in predictive testing. It is possible that 
an assessment of impact of the patient’s RA over time, rather than over the previous week as captured 
by the RAID questionnaire, may have been predictive. However, long term impact of RA is reflected 
by whether or not the proband is taking biologic drugs for RA, which was not associated with FDRs’ 
interest in predictive testing in the current study. 
These findings increase understanding of perceptual variation amongst those at risk of developing RA. 
Further research is needed to explore interest in different types of predictive tests for RA (e.g. multi-








































































omics technologies) and tests with different performance characteristics (e.g. high positive predictive 
value versus high negative predictive value). 
Strengths and limitations 
This study has several methodological strengths, including a large sample, paired data linking FDRs 
with index patients, multidisciplinary contributors, and extensive patient involvement. Six predictors 
were included, and the sample size was sufficient using the rule of thumb of a minimum of 10 cases 
per predictor, although it is acknowledged that the fraction of patients in the ‘Not interested’ category 
was lower than expected. A further strength includes recruitment of FDRs via patients with a 
confirmed diagnosis, rather than individuals self-reporting family history. This is important as people 
often confuse RA with other conditions, such as osteoarthritis.[47]
As FDR recruitment relied on patients passing the survey to their FDRs, the study may be subject to 
selection bias. Recruitment of FDRs is challenging [48,49] and further research is needed to compare 
alternative strategies and investigate predictors of the likelihood that patients will pass on RA risk 
information to their relatives. Additionally, recruiting FDRs in this manner meant that no data were 
available for FDRs who did not respond to the survey. It would be informative to understand the 
characteristics and views of this group. Further work using alternative methodologies is needed to 
understand the views of FDRs who are unlikely to respond to a survey of this kind.
No objective measure assessed patients’ disease activity in this study. Further investigation is needed 
to examine associations between FDRs’ interest in testing and measures of patients’ disease activity 
including objective elements (e.g., DAS28). Furthermore, participants in this cross-sectional study 
were linked with one family member with RA, but may have had experience of other relatives from 
previous generations who may have been more severely affected by RA. Further investigation is 
needed to comprehensively assess relationships between FDRs’ interest in predictive testing for RA 
and their experience of the impact of RA on their family members, and how this varies over time. 
However, this experience is likely to be reflected in their illness perceptions, which were assessed in 
this study.
Finally, female participants of white British ethnicity are over-represented in the present sample. 
Conclusions
FDRs’ interest in predictive testing for RA was high. Several predictors were identified, including 
information-seeking preferences, beliefs that predictive testing would increase empowerment over 
health and desire for RA risk knowledge. FDRs who perceived themselves to be “neither likely or 
unlikely”, or perceived themselves to be “unlikely” to develop RA were less interested in taking a 








































































predictive test compared to those who perceived themselves to be “very likely” to develop RA. Finally, 
beliefs that testing could lead to psychological harm predicted lower interest. These findings will 
inform development of effective predictive strategies and information to support decision-making in 
individuals considering predictive tests for RA or taking part in prospective and preventive research.
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Table 1: Distribution of scores for FDRs' interest in taking a predictive test.
Interest in taking a predictive 
test
Number of relatives (N=393)a Percentage (%)
Yes definitely 218 55.5
Yes probably 141 35.9
No probably not 29 7.4
No definitely not 5 1.3
  aN=3 (0.8%) missing responses from relatives.








































































Table 2: Descriptive statistics and univariate analyses for FDRs’ characteristics and associations with interest in testing (N=396).
FDRs’ characteristics Descriptive statistics Association with interest in 
predictive testing
Statistics P
Age (years) (N=16 missing); median (IQR) 42 (30-53) -0.07 rs 0.16 
Deprivation index (N=82 missing); median (IQR) 4 (2-7) -0.05 rs 0.41 
Gender (N=6 missing); frequency (%) 0.15 
    Male 137 (35.1) 3(2-3) U
    Female 253 (64.9) 3(2-3) U
Employment (N=6 missing); frequency (%) 0.08 
    Employed 297 (76.2) 3(2-3) H
    Unemployed 62 (15.9) 3(2-3) H
    Other 31 (7.9) 3(2-3) H
Ethnic Group (N=2 missing); frequency (%) 0.76 
    White 328 (83.2) 3(2-3) H
    Mixed 15 (3.8) 3(2-3) H
    Asian 36 (9.1) 3(2-3) H
    Black 14 (3.6) 3 (2-3) H
    Other 1 (0.3) 3 (3-3) H
Smoking (N=8 missing); frequency (%) 0.62 
    Current 40 (10.3) 3(2-3) H
    Ever 111 (28.6) 3(2-3) H
    Never 237 (61.1) 3(2-3) H
Education (N=17 missing); frequency (%) 0.65 
   A level or lower 187 (49.3) 3(2-3) U
   Higher than A level 192 (50.7) 3(2-3) U
Type of Relative (N=4 missing); frequency (%) <0.001 
     Child 295 (75.3) 3(2-3) U
     Sibling 97 (24.7) 2(2-3) U
Living with index patient (N=2 missing); frequency (%) 0.45 
    Yes 77 (19.5) 2(2-3) U 
    No 317 (80.5) 3(2-3) U








































































Frequency of talking to index patient (N=4 missing); frequency (%) 0.12 rs 0.02 
    Never 0
    Rarely 4 (1)
    Sometimes 20 (5.1)
    Often 154 (39.3)
    Daily 214 (54.6)
Perceived absolute risk (N=2 missing); frequency (%) 3 (2-3) 0.33 rs <0.001 
    Very unlikely 5 (1.3)
    Unlikely 31 (7.9)
    Neither likely nor unlikely 101 (25.6)
    Likely 202 (51.3)
    Very likely 55 (14.0)
Perceived relative risk (N=2 missing); frequency (%)) 3 (2-3) 0.34 rs <0.001 
    Much less likely 6 (1.5)
    Less likely 17 (4.3)
    About the same 155 (39.3)
    More likely 174 (44.2)
    Much more likely 42 (10.7)
Perceived experiential risk (N=1 missing); frequency (%) 3 (2-3) 0.32 rs <0.001 
    Strongly disagree 3 (0.8)
    Disagree 28 (7.1)
    Neither agree nor disagree 92 (23.3)
    Agree 211 (53.4)
    Strongly agree 61 (15.4)
Worry about risk (N=1 missing); frequency (%) 3 (2-3) 0.29 rs <0.001 
    Strongly disagree 12 (3.0)
    Disagree 42 (10.6)
    Neither agree nor disagree 116 (29.4)
    Agree 166 (42.0)
    Strongly agree 59 (14.9)
Health literacy (N=4 missing); frequency (%) 0 (0-0) 0.004 rs 0.95
   Never 306 (78.1)
   Rarely 49 (12.5)








































































   Sometimes 26 (6.6)
   Often 6 (1.5)
   Always 5 (1.3)
Subjective numeracy (N=4 missing); median (IQR) 15.00 (11.25-17.75) -0.05 rs 0.33 
Brief illness perception questionnaire; median (IQR)
     Consequences (N=5 missing) 8 (7-9) 0.14 rs 0.006 
     Timeline (N=5 missing) 10 (9-10) 0.14 rs 0.007 
     Personal control (N=5 missing) 5 (3-7) -0.03 rs 0.52 
     Treatment control (N=5 missing) 7 (5-8) -0.02 rs 0.72
     Identity (N=4 missing) 8 (7-8) 0.11 rs 0.03 
     Concern (N=2 missing) 8 (7-10) 0.21 rs <0.001 
     Understanding (N=2 missing) 7 (6-9) 0.10 rs 0.04 
     Emotional (N=2 missing) 7 (6-9) 0.11 rs 0.03 
Information Seeking (N=4 missing); median (IQR) 84.38 (75.00-93.75) 0.34 rs <0.001 
Decision making (N=1 missing); median (IQR) 58.33 (45.83-70.83) -0.02 rs 0.73 
Brief Avoidance Coping Questionnaire (N=9 missing); median (IQR) 30 (26-34) 0.12 rs 0.02 
Optimism (N=5 missing); median (IQR) 7 (6-9) 0.06 rs 0.25 
Health anxiety overall (N=17 missing); median (IQR) 12 (8-18) 0.14 rs 0.006 
Attitudes towards testing– median (IQR)
    Desire for risk knowledge (N=62 missing) 1.08 (0.72-1.37) 0.47 rs <0.001 
    Psychological harm to self as a result of knowing risk (N=49 missing) 1.00 (0.66-1.41) -0.18 rs 0.001 
    Increased empowerment over health (N=7 missing) 1.98 (1.79-2.35) 0.42 rs <0.001 
    Family (di)stress associated with experience of getting a test (N=2 missing) 1.29 (0.79-1.84) -0.15 rs 0.003 
    Accuracy of predictive testing (N=6 missing) 1.72 (0.86-2.58) 0.17 rs 0.001 
    Social consequences as a result of testing (N=4 missing) 1.24 (0.82-1.64) -0.06 rs 0.27 
rs= Spearman’s rank correlation, H= Kruskal-Wallis H test, U= Mann-Whitney U test. Correlation coefficients are reported for Spearman’s rank correlations, 
medians and IQRs are reported for Kruskal-Wallis H and Mann-Whitney U tests. 








































































Table 3: Final ordinal logistic regression model to predict FDRs’ interest in predictive testing.
N=80/396 missing cases. 
FDRs’ predictors  Odds ratio (OR) 
(95% CI)
P Value
Desire for RA risk knowledge 7.03 (3.51 to 
14.12)
<0.001
Information seeking preferences 1.03 (1.01 to 1.06) 0.005
Increased empowerment over health 2.64 (1.25 to 5.59) 0.011
Perceived absolute risk (reference category- very likely)
   Likely 0.44 (0.16 to 1.23)  0.118
   Neutral 0.20 (0.07 to 0.58)  0.003
   Unlikely 0.22 (0.06 to 0.75) 0.016
   Very unlikely 0.24 (0.02 to 3.07) 0.270
Psychological harm to self as a result of knowing risk 0.36 (0.23 to 0.58) <0.001
Frequency of talking to index patient (reference category-everyday)
  Rarely 0.49 (0.05 to 5.36) 0.561
Sometimes 0.39 (0.13 to 1.14) 0.085
   Often 1.43 (0.84 to 2.43) 0.186








































































Table 4: Descriptive statistics and GEEs examining impact of patient characteristics on FDRs’ interest in testing (N=214).




for patients whose 
relatives were 
definitely interested 
in taking a test 
(N=150) 
Descriptive statistics 
for patients whose 
relatives were 
probably interested 






not interested in 





Age (years) (N=7 missing); median (IQR) 64 (55-73) 64 (55-73) 64 (54-70) 65 (60-75) 0.20 0.66
Deprivation index (N=32 missing); median (IQR) 4 (2-6) 4 (2-6) 4 (2-7) 3 (2-4.75) 10.60 0.31
Gender (N=6 missing); frequency (%) 3.98 0.05
   Male 50 (24) 39 (26.7) 23 (20.7) 2 (7.7)
   Female 158 (76) 107 (73.3) 88 (79.3) 24 (92.3)
Employment (N=1 missing); frequency (%) 0.84 0.36
    Employed 63 (29.6) 37 (24.8) 36 (31.9) 7 (25.9)
    Unemployed 148 (69.5) 109 (73.2) 77 (68.1) 20 (74.1)
    Other 2 (0.9) 3 (2.0) 0 0
Ethnic Group (N=2 missing); frequency (%) 6.90 0.08
    White 180 (84.9) 124 (83.8) 95 (84.1) 24 (88.9)
    Mixed 4 (1.9) 2 (1.4) 4 (3.5) 1 (3.7)
    Asian 18 (8.5) 17 (11.5) 8 (7.1) 1 (3.7)
    Black 10 (4.7) 5 (3.4) 6 (5.3) 1 (3.7)
    Other 0 0 0 0
Smoking (N=3 missing); frequency (%) 1.43 0.49
    Current 17 (8.1) 12 (8.1) 8 (7.1) 1 (3.7)
    Ever 70 (33.2) 58 (39.2) 40 (35.7) 9 (33.3)
    Never 124 (58.8) 78 (52.7) 64 (57.1) 17 (63)
Education (N=13 missing); frequency (%) 2.38 0.12
    A level or lower 135 (67.2) 103 (73) 70 (63.6) 16 (66.7)
   Higher than A level 66 (32.8) 38 (27) 40 (36.4) 8 (33.3)
RA duration (years) (N=43 missing); median 
(IQR)
10 (4-20) 10 (4-16) 10 (4-20) 0.62 0.43








































































RAID scorea (N=8 missing); median (IQR) 5.00 (3.00-
7.00)
5.23 (2.95-7.00) 5.30 (2.07-7.03) 5.30 (2.85-7.26) 0.49 0.48
    Pain 5 (3-7) 5 (3-7) 5 (3-8) 5 (3-7) 19.32 0.04
    Ability 5 (2-7) 6 (2-8) 5 (2-8) 5 (2.75-7.25) 14.23 0.16
    Fatigue 6 (3-8) 6 (4-8) 6 (3-8) 6 (3.75-8) 7.66 0.66
    Sleep 5 (2-8) 6 (3-8) 5 (2-8) 5 (2-7) 7.49 0.68
    Physical wellbeing 5 (3-7) 5 (3-8) 5 (2-7) 4 (3-7) 10.61 0.30
    Emotional wellbeing 4 (2-7) 5 (3-7) 5 (1-7) 4 (2-7) 16.44 0.09
    Coping 4 (2-6) 4 (2-6) 4 (1-6) 4 (2-6) 17.42 0.07
Current treatment; frequency (%)
    No treatment 4 (1.9) 3 (2.0) 2 (1.8) 1 (3.7) 0.001 0.97
    Conventional synthetic DMARDs and 
glucocorticoids 
189 (88.3) 135 (90) 95 (84.1) 23 (85.2) 1.40 0.24
    Biologic DMARDs 67 (31.3) 47 (31.3) 36 (31.9) 11 (40.7) 0.47 0.50
a Rheumatoid Arthritis Impact of Disease score
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